Remove Drug Research Remove Drugs Remove Pharma Companies
article thumbnail

ACTO EXPANDS INVESTMENT IN ARTIFICIAL INTELLIGENCE TO SOLVE UNMET NEEDS IN THE LIFE SCIENCES INDUSTRY

ACTO

“The life sciences industry is actively looking for new ways to leverage AI to bring drugs to market faster to patients waiting in need,” said Parth Khanna, CEO of ACTO. We see ACTO as a category leader with their powerful AI-first platform, which empowers pharma companies to consistently turn their field reps into top performers.

Science 52